AGARWALEYENSEDr. Agarwal's Health Care LimitedHighPositive
Announced Mon, 11 May · 17:51 IST

Dr. Agarwal's Health Care Limited has informed the Exchange about the Receipt of Order passed by the Hon ble NCLT, Chennai Bench, in relation to the Scheme of amalgamation between Dr. Agarwal s Eye Hospital Limited and Dr. Agarwal s Health Care Limited

Regulatory & Legal View source PDF

AGARWALEYE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-3.2%1-day move
₹464.80
prior close
₹460.85
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.2-0.4+0.2-3.2-4.3-3.0-5.3-2.3+3.7-0.9-5.3+7.1
Up moveDown movePending
AI summary

NCLT Chennai Bench passed an order on May 5, 2026, allowing a joint application by Dr. Agarwal's Eye Hospital Limited (AEHL) and Dr. Agarwal's Health Care Limited (AHCL) for amalgamation. The tribunal directed both companies to convene meetings of their equity shareholders, secured creditors, and unsecured creditors on July 2, 2026, to consider and approve the scheme of amalgamation. The certified copy of the order is awaited. The amalgamation remains subject to necessary statutory and regulatory approvals after the meetings.

Likely market impact

This is a procedural step in the amalgamation process. Shareholder and creditor approvals at the meetings, followed by final regulatory clearances, will determine the scheme's success. The stock may see movement on speculation of consolidation benefits once meetings approach.